These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34592937)

  • 1. An overview of bacterial meningitis epidemics in Africa from 1928 to 2018 with a focus on epidemics "outside-the-belt".
    Mazamay S; Guégan JF; Diallo N; Bompangue D; Bokabo E; Muyembe JJ; Taty N; Vita TP; Broutin H
    BMC Infect Dis; 2021 Sep; 21(1):1027. PubMed ID: 34592937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
    Mustapha MM; Harrison LH
    Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the spatio-temporal dynamics of meningitis epidemics outside the belt: the case of the Democratic Republic of Congo (DRC).
    Mazamay S; Bompangue D; Guégan JF; Muyembe JJ; Raoul F; Broutin H
    BMC Infect Dis; 2020 Apr; 20(1):291. PubMed ID: 32312246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
    Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
    Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
    PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study.
    Azure S; Abdul-Karim A; Abubakari BB; Eleeza JB; Agboyie DDA; Weyori EW; Choi JY
    BMC Infect Dis; 2023 Apr; 23(1):202. PubMed ID: 37024833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.
    Sidikou F; Potts CC; Zaneidou M; Mbaeyi S; Kadadé G; Paye MF; Ousmane S; Issaka B; Chen A; Chang HY; Issifou D; Lingani C; Sakande S; Bienvenu B; Mahamane AE; Diallo AO; Moussa A; Seidou I; Abdou M; Sidiki A; Garba O; Haladou S; Testa J; Obama Nse R; Mainassara HB; Wang X
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S206-S215. PubMed ID: 31671439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
    ; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
    Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
    Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Sadji AY; Poy AN; Lingani C; Tall H; Sakandé S; Tarbangdo F; Aké F; Mbaeyi SA; Moïsi J; Paye MF; Sanogo YO; Vuong JT; Wang X; Ronveaux O; Novak RT;
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S165-S174. PubMed ID: 31671441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of emerging vaccines for childhood meningococcal disease.
    Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
    Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
    Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.
    Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X
    mSphere; 2016; 1(6):. PubMed ID: 27904879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.
    Topaz N; Caugant DA; Taha MK; Brynildsrud OB; Debech N; Hong E; Deghmane AE; Ouédraogo R; Ousmane S; Gamougame K; Njanpop-Lafourcade BM; Diarra S; Fox LM; Wang X
    EBioMedicine; 2019 Mar; 41():488-496. PubMed ID: 30846392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.
    Kretz CB; Retchless AC; Sidikou F; Issaka B; Ousmane S; Schwartz S; Tate AH; Pana A; Njanpop-Lafourcade BM; Nzeyimana I; Nse RO; Deghmane AE; Hong E; Brynildsrud OB; Novak RT; Meyer SA; Oukem-Boyer OOM; Ronveaux O; Caugant DA; Taha MK; Wang X;
    Emerg Infect Dis; 2016 Oct; 22(10):1762-1768. PubMed ID: 27649262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
    Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.